Technical Analysis for EXAI - Exscientia Limited
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Wide Bands | Range Expansion | 0.00% | |
| NR7 | Range Contraction | -5.84% | |
| Narrow Range Bar | Range Contraction | -5.84% | |
| Wide Bands | Range Expansion | -5.84% | |
| Wide Bands | Range Expansion | -6.40% | |
| New Downtrend | Bearish | 0.21% | |
| Wide Bands | Range Expansion | 0.21% | |
| Gapped Up | Strength | 0.21% | |
| Overbought Stochastic | Strength | 0.21% | |
| Weak + Overbought | Other | -8.06% |
| Alert | Time |
|---|---|
| Down 1 ATR | about 8 hours ago |
| Down 5% | about 12 hours ago |
| Fell Below 10 DMA | about 12 hours ago |
| 60 Minute Opening Range Breakdown | about 12 hours ago |
| Down 3% | about 14 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/20/2024
Exscientia is an AI-driven pharmatech company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Our pipeline demonstrates our ability to rapidly translate scientific concepts into precision-designed therapeutic candidates, with more than 25 projects advancing, including the first three AI-designed drug candidates to enter Phase 1 clinical trials.
Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Artificial Intelligence Health Sciences Clinical Trial Precision Medicine Clinical Pharmacology Systems Biology Evidence Based Medicine
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Life Sciences Artificial Intelligence Health Sciences Clinical Trial Precision Medicine Clinical Pharmacology Systems Biology Evidence Based Medicine
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.12 |
| 52 Week Low | 3.86 |
| Average Volume | 651,175 |
| 200-Day Moving Average | 5.84 |
| 50-Day Moving Average | 5.31 |
| 20-Day Moving Average | 4.55 |
| 10-Day Moving Average | 4.71 |
| Average True Range | 0.36 |
| RSI (14) | 46.81 |
| ADX | 23.36 |
| +DI | 20.53 |
| -DI | 27.99 |
| Chandelier Exit (Long, 3 ATRs) | 4.22 |
| Chandelier Exit (Short, 3 ATRs) | 4.95 |
| Upper Bollinger Bands | 5.26 |
| Lower Bollinger Band | 3.84 |
| Percent B (%b) | 0.59 |
| BandWidth | 31.37 |
| MACD Line | -0.10 |
| MACD Signal Line | -0.21 |
| MACD Histogram | 0.1079 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.11 | ||||
| Resistance 3 (R3) | 5.13 | 5.01 | 5.04 | ||
| Resistance 2 (R2) | 5.01 | 4.90 | 5.00 | 5.01 | |
| Resistance 1 (R1) | 4.84 | 4.83 | 4.78 | 4.82 | 4.99 |
| Pivot Point | 4.72 | 4.72 | 4.69 | 4.71 | 4.72 |
| Support 1 (S1) | 4.56 | 4.61 | 4.50 | 4.54 | 4.37 |
| Support 2 (S2) | 4.44 | 4.55 | 4.43 | 4.35 | |
| Support 3 (S3) | 4.27 | 4.44 | 4.32 | ||
| Support 4 (S4) | 4.25 |
